Patient selection in sepsis: precision medicine using phenotypes and its implications for future clinical trial design.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

1. Sepsis subphenotypes: bridging the gaps in sepsis treatment strategies.Frontiers in immunology · 2025
   Review
2. Clinical Sepsis Phenotypes in Critically Ill Patients.Microorganisms · 2023
   Review
3. Identification of acute kidney injury subphenotypes.Current opinion in critical care · 2020
   Review

Corrections and comments

• Comment on
  Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis.2019

Authors and funding

2 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.